IP84-18: Markers of systemic immune activation do not predict tumor response based on immune related residual viable tumor (%irRVT)

IP84-18: Markers of systemic immune activation do not predict tumor response based on immune related residual viable tumor (%irRVT)

Monday, May 18, 2026 9:30 AM to 11:30 AM · 1 hr. 59 min. (America/New_York)
147B
Abstract

Registered attendees

Alexander Kutikov
Alexander Kutikov
Chair, Urology and Urologic OncologyFox Chase Cancer Center
David Chen
David Chen
ProfessorFox Chase Cancer Center-Temple Health Urologic Institute
David Han
David Han
FellowFox Chase-Temple Urologic Institute

Log in

See all the content and easy-to-use features by logging in or registering!